CAMK2G and glioblastoma: To further assess the effect of the simultaneous treatment with CaMKII and NK1R inhibitors on GBM tumorigenesis by GSCs in vivo, we used a chick chorioallantoic membrane (CAM) tumor model implanted with U87MG GSCs.